JAMP-Pregabalin 50 mg capsules

Check your medication bottle to ensure it only contains 50 mg capsules. The 50 mg capsule is white with “PG” and “50” printed on it in black ink. The 150 mg capsule is white with “PG” and “150” printed on it in black ink. If it contains any 150 mg capsules, or if you are unsure, return it to your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement, if needed. If you are unable to return your capsules to the pharmacy right away, talk to your pharmacist or doctor for further guidance. Seek immediate medical attention if you are experiencing symptoms of an overdose (e. G. , confusion, agitation, restlessness and seizures). Do not stop taking pregabalin without first speaking to your doctor, as stopping abruptly may result in withdrawal symptoms. If you have questions about this recall, contact JAMP Pharma Corp. By calling 1-866-399-9091, extension 501, or by emailing custjamp@jamppharma. Com. Report any health product-related side effects or complaints to Health Canada. Additional information for health professionals. Health care professionals, such as pharmacists, should check manufacturer 100-capsule bottles labelled as JAMP-Pregabalin 50 mg capsules before dispensing to ensure they do not contain 150 mg capsules. Report any unusual bottles or other issues to the company and to Health Canada.